Rosario Di Maggio

The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major‐intermedia dichotomy?

Angela Vitrano, Giuseppina Calvaruso, Eliana Lai et al. · British Journal of Haematology · 2016 · 56 citations · Full text

Heart Failure, Iron Metabolism, Prognosis +19

Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial

Farid Boulad, Aurelio Maggio, Xiuyan Wang et al. · Nature Medicine · 2022 · 45 citations · Full text

Medicine, Phase 1, Hematology +1

Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5‐year long‐term <scp>I</scp>talian multicenter randomized clinical trial

Giuseppina Calvaruso, Angela Vitrano, Rosario Di Maggio et al. · American Journal of Hematology · 2015 · 44 citations · Full text

Long‐term use of deferiprone significantly enhances left‐ventricular ejection function in thalassemia major patients

Aurelio Maggio, Angela Vitrano, Gaetano Lucania et al. · American Journal of Hematology · 2012 · 36 citations · Full text

Left‐ventricular Ejection Function, Heart Failure, Versus Dfp +13

Incidence of cancer and related deaths in hemoglobinopathies: A follow‐up of 4631 patients between 1970 and 2021

Raffaella Origa, Barbara Gianesin, Filomena Longo et al. · Cancer · 2022 · 24 citations · Full text